• Home
  • Products & Services
    • VBS Pharmaceuticals
      • CAR Peptide Technology
      • CAR Peptide Applications
        • Co-administered Therapeutics
        • Pulmonary Hypertension
        • Sepsis
        • Gene Therapy
    • VBS Interventional
      • Interventional Technology
        • Endoarterial Biopsy Catheter
        • Endoarterial Biopsy Procedure
        • Endoarterial Biopsy Sequence
        • Endoarterial Biopsy Sample
        • Single Use Components
        • Endoarterial Biopsy Kit
      • Interventional Applications
        • Pulmonary Arterial Hypertension
        • Peripheral Vascular Disease
        • Lung Transplant Rejection
        • Vasculitis/Collagen Vascular Disease
        • Coronary Artery Disease
        • Critical Care Applications — Acute Lung Injury & Acute Respiratory Distress Syndrome
        • Lung Cancer
    • VBS Molecular Diagnostics
      • Molecular Diagnostics Technology
  • Product Pipeline
  • COVID-19
  • News
  • About VBS
    • VBS Team
    • VBS Board of Directors
  • VBS Scientific Articles
  • Investment
  • Contact

Vascular BioSciences congratulates VP of Communications, Dr. Susana Peinado, Ph.D., on being awarded her Doctorate from UCSB School of Communication

Jun 07, 2016

Goleta, Ca, June 7, 2016 — Vascular BioSciences announced today that Dr. Susana Peinado, Ph.D., Vice President of Communications at Vascular BioSciences, was awarded a doctoral degree from the UCSB School of Communication.

In addition to her outstanding work at Vascular Biosciences, Dr. Peinado has received numerous awards for her accomplishments, including a Dean’s Advancement Fellowship, a Health Communication Doctoral Fellowship at the Cancer Communication Research Center, National Cancer Institute, a Graduate Opportunity Fellowship, and a SAGE Sara Miller McCune Fellowship.

Dr. Peinado’s dissertation research, “The Use of Emotional Shifts in Health Messages as a Strategy for Generating Talk and Promoting Attitude, Belief, and Behavior Change”, focused on how conversation following exposure to health messages influences attitudes and behavior.

“We are extremely proud of Dr. Peinado and all of her achievements,” said David Mann, CEO and Chairman of Vascular BioSciences and VBS Pharmaceuticals. “Dr. Peinado’s accomplishment is a testament to her hard work and dedication to the field of health communication, and we are proud to have her as part of our team here at Vascular BioSciences.”

About Vascular BioSciences
Vascular BioSciences, a diversified biomedical company with operations in California and North Carolina, provides targeted solutions for serious diseases in order to enhance and prolong human life.

Vascular BioSciences makes interventional catheters to obtain endoarterial biopsies, provides molecular diagnostic services, and through its majority owned subsidiary VBS Pharmaceuticals, develops targeted therapeutics for patients with difficult-to-treat diseases.

For more information about VBS is available at www.vascularbiosciences.com/

For more information, please contact dmann@vascularbiosciences.com

  • Home
  • Products & Services
  • Product Pipeline
  • News
  • About VBS
  • VBS Scientific Articles
  • Investment
  • Contact Info
  • Privacy Policy